These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20887388)

  • 1. Vitamin K2 modulates differentiation and apoptosis of both myeloid and erythroid lineages.
    Sada E; Abe Y; Ohba R; Tachikawa Y; Nagasawa E; Shiratsuchi M; Takayanagi R
    Eur J Haematol; 2010 Dec; 85(6):538-48. PubMed ID: 20887388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment of leukemia cells with vitamin K2 and 1alpha,25-dihydroxy vitamin D3 enhances monocytic differentiation along with becoming resistant to apoptosis by induction of cytoplasmic p21CIP1.
    Iguchi T; Miyazawa K; Asada M; Gotoh A; Mizutani S; Ohyashiki K
    Int J Oncol; 2005 Oct; 27(4):893-900. PubMed ID: 16142303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI; Bolaraki PE; Voulgarelis M
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.
    Shen S; Passioura T; Symonds G; Dolnikov A
    Exp Hematol; 2007 Jun; 35(6):908-19. PubMed ID: 17533045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic disulfide-triggered apoptosis and erythroid differentiation in myelodysplastic syndrome and acute myeloid leukemia cell lines.
    Hu XM; Yuan B; Tanaka S; Song MM; Onda K; Tohyama K; Zhou AX; Toyoda H; Hirano T
    Hematology; 2014 Sep; 19(6):352-60. PubMed ID: 24192507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
    Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
    Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells.
    Funato K; Miyazawa K; Yaguchi M; Gotoh A; Ohyashiki K
    Leukemia; 2002 Aug; 16(8):1519-27. PubMed ID: 12145693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific expression of heterotrimeric G proteins G12 and G16 during human myeloid differentiation.
    Tenailleau S; Corre I; Hermouet S
    Exp Hematol; 1997 Aug; 25(9):927-34. PubMed ID: 9257805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes.
    Maratheftis CI; Andreakos E; Moutsopoulos HM; Voulgarelis M
    Clin Cancer Res; 2007 Feb; 13(4):1154-60. PubMed ID: 17317824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCL expression at critical points in human hematopoietic lineage commitment.
    Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
    Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dominant-negative mutant of C/EBPalpha, associated with acute myeloid leukemias, inhibits differentiation of myeloid and erythroid progenitors of man but not mouse.
    Schwieger M; Löhler J; Fischer M; Herwig U; Tenen DG; Stocking C
    Blood; 2004 Apr; 103(7):2744-52. PubMed ID: 14656889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-II: a novel autocrine growth factor modulating the apoptosis and maturation of umbilical cord blood erythroid progenitors.
    Nagatomo T; Muta K; Ohga S; Ochiai M; Ohshima K; Hara T
    Exp Hematol; 2008 Apr; 36(4):401-11. PubMed ID: 18261839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel role of vitamin K2: a potent inducer of differentiation of various human myeloid leukemia cell lines.
    Sakai I; Hashimoto S; Yoda M; Hida T; Ohsawa S; Nakajo S; Nakaya K
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1305-10. PubMed ID: 7802663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell factor and interleukin-3 induce stepwise generation of erythroid precursor cells from a basic fibroblast growth factor-dependent hematopoietic stem cell line, A-6.
    Anzai H; Ikawa Y; Atsumi T
    Biochem Biophys Res Commun; 2001 Apr; 282(4):940-6. PubMed ID: 11352642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanisms of vitamin K2-induced apoptosis of myeloma cells.
    Tsujioka T; Miura Y; Otsuki T; Nishimura Y; Hyodoh F; Wada H; Sugihara T
    Haematologica; 2006 May; 91(5):613-9. PubMed ID: 16670066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells.
    Josefsen D; Myklebust JH; Lømo J; Sioud M; Blomhoff HK; Smeland EB
    Stem Cells; 2000; 18(4):261-72. PubMed ID: 10924092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of vitamin K2 plus imatinib mesylate enhances induction of apoptosis in small cell lung cancer cell lines.
    Yokoyama T; Miyazawa K; Yoshida T; Ohyashiki K
    Int J Oncol; 2005 Jan; 26(1):33-40. PubMed ID: 15586222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.